naringenin and Atherosclerotic Parkinsonism

naringenin has been researched along with Atherosclerotic Parkinsonism in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sekar, S; Sevanan, M; Sugumar, M1
Ambasta, RK; Anand, K; Kumar, P; Sarkar, A; Sonia Angeline, M1

Other Studies

2 other study(ies) available for naringenin and Atherosclerotic Parkinsonism

ArticleYear
Neuroprotective effect of naringenin against MPTP-induced oxidative stress.
    The International journal of neuroscience, 2019, Volume: 129, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catalase; Corpus Striatum; Dose-Response Relationship, Drug; Flavanones; Glutathione Reductase; Lipid Peroxidation; Male; Mice; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; Parkinson Disease, Secondary; Substantia Nigra

2019
Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.
    Neuroscience, 2013, Dec-19, Volume: 254

    Topics: Animals; Benzodioxoles; Disease Models, Animal; Flavanones; Male; Parkinson Disease, Secondary; Phenols; Rats; Rats, Wistar; Rotenone

2013